THE IMPACT OF ATRIAL FIBRILLATION IN CARDIAC SURGERY Wim J De Vries. DEPARTMENT CARDIOTHORACIC SURGERY UNIVERSITY OF THE FREE STATE UNIVERSITAS HOSPITAL.

Slides:



Advertisements
Similar presentations
Beta Blockers In Anesthesia. Introduction Introduction.
Advertisements

Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Introduction Recent guidelines considered PCI to be a potential alternative to CABG for ULMCA stenosis, based on several large registries and randomized.
Impact of Preoperative Renal Dysfunction in Patients Undergoing Off- pump vs On-pump Coronary Artery Bypass.
Stenting Patients Needing Non-Cardiac Surgery
Prognostic Value of Left Myocardial performance index (LVMPI) in patients undergoing CABG.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
PREOPERATIVE ASSESSMENT OF THE GERIATRIC PATIENT Cheryl Hinners M.D.
Cardiovascular Pre-Operative Evaluation for Non-Cardiac Surgery Jessica Thom PGY-1.
AVE Micro Stent KFSH & RC Experience with 6 months Angiographic Follow Up Layth A. Mimish, M. Bakhshi, F. Al-Nozha, A. Kinsara, O. Amoudi, J. Buraiki,
CABG GUIDELINES SANJAY DRAVID, M.D.. INTRODUCTION ACC/AHA GUIDELINE UPDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (JACC 2004; 44: AND CIRCULATION.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Ischemic Heart Diseases IHD
Epidemiology of Stroke Dexter L. Morris, PhD, MD Department of Emergency Medicine University of North Carolina School of Medicine Chapel Hill, NC.
Valvular heart surgery in Rajavithi hospital Dr.WITTAWAT PIBUL Rajavithi Hospital.
5 Years Results of Off-Pump VS On-Pump CABG 5 Years Results of Off-Pump VS On-Pump CABG Prospective Non-randomized Comparative Study Piya Cherntanomwong*,
Late outcomes of the Cox-Maze IV procedure for atrial fibrillation Matthew C. Henn MD, Timothy S. Lancaster MD, Jacob R. Miller MD, Laurie A. Sinn RN,
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Open Repair of Ruptured Descending Thoracic and Thoracoabdominal Aortic Aneurysms in 100 Consecutive Cases Mario F. Gaudino, Christopher Lau, Monica Munjal,
Seung-Jung Park, MD, PhD On behalf of the PRECOMBAT Investigators Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan.
Angiography Excessive Commercialisation Complications of Angiography 1.Death 2.Myocardial Infarction Factors predisposing Unstable angina Angina at rest.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
C.H.T Dr.Salarifar 1 Tehran Heart Center Tehran University of Medical Sciences PCI VS CABG M. SALARIFAR, MD.
Atrial Fibrillation Dr Nidhi Bhargava 8/10/13.
Call for CASES Staged PCI in a patient with multivessel coronary disease disqualified from CABG. Pawel Buszman, MD, FESC, FSCAI Marcin Debinski, MD Krzysztof.
Simultaneous Coronary Artery Bypass and Carotid Endarterectomy Ye zhidong, Liu Peng Department of Cardiovascular Surgery China-Japan Friendship Hospital.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
New guidelines for CABG
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Cardiac Intervention in the Elderly. Cardiac Interventions Coronary Artery Bypass Grafting (CABG) Percutaneous Transluminal Coronary Angioplasty (PTCA)
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Main results Swedberg K, et al. Lancet. 2010;376(9744):
André Lamy Population Health Research Institute Hamilton Health Sciences McMaster University Hamilton, CANADA on behalf of the CORONARY Investigators Disclosures.
1 Aortic Symposium 2010 Andrew W. ElBardissi, MD, MPH Sary F. Aranki, MD Lawrence H. Cohn, MD Stanton K. Shernan, MD Daniel J. FitzGerald, CCP, LP R. Morton.
G. Rainey Williams Symposium September 30, 2005 CABG in the Elderly Patient: On or Off pump? A Single Center Experience R. Nathan Grantham, M.D.
Strokes in Ascending Aortic Repairs: Predictive and Protective Factors Tovy Kamine, BS, Steven R Messé, MD, Elizabeth Leitner, Joseph Bavaria, MD, Michael.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
Renal involvement in Henoch-Schönlein purpura Anca Lupu 6 th year (Bagdasar Alina, Gabor Estera) – Faculty of Medicine Scientific supervisor: Associate.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
ANTIPLATELET TREATMENT IN PATIENTS WHO HAVE AN ISCHEMIC STROKE WHILE TAKING ASPIRIN Konstantinos Tziomalos, Stella D. Bouziana, Marianna Spanou, Stavroula.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
The Impact of Prior Stroke on the Outcome of Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Romain Didier, MD;
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Atorvastatin Versus Revascularization Treatments (AVERT) Trial Presented at The American Heart Association Scientific Sessions 1998 Presented by Dr. Bertram.
Balloon-pump assisted Coronary Intervention Study BCIS-1 Simon Redwood Divaka Perera, Rod Stables, Martyn Thomas.
Outcome of Increasingly Morbid Cardiac Patients Prof. Abdulhamid Al-Saeed, FFARCSI Professor in Anaesthesia & Critical Care Medicine Head of Cardiac Anaesthesia.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Oncology Institute of Vojvodina Department of anaesthesiology and intensive care Institutski put 4, Sremska Kamenica, SERBIA
Department of cardiovascular surgery Kumamoto Central Hospital Taro Nakatsu, Nobushige Tamura, Takuya Nomoto, Koji Hagio, Masanosuke Ishigami, Shouichi.
Hybrid Off-Pump Revascularization; Early & Midterm Results 서울대학교병원 흉부외과 황 호영, 조 광리, 김 기봉.
Segment 1 Perioperative Risk Assessment. Need Advice – How Low is Low Dear Consult Sages ; I need your help and guidance to provide better service to.
Objective Bleeding events are grave and sometimes life threatening complications after prosthetic valve replacement, especially in hemodialysis patients.
© Continuing Medical Implementation ® …...bridging the care gap Geriovascular Prevention Optimizing Prevention of Cardiovascular Disease in the Elderly.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
ISCHEMIC HEART DISEASE
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
Is There a Need to Address AF in patients Undergoing Valve Surgery?
Procedural factors associated with PCI-related ischemic stroke
Successful Cox Maze Procedure During Mitral Valve Surgery Restores Patient Survival Without Increasing Operative Risk Niv Ad, MD Chief, Cardiac Surgery.
Pre-Operative Inotropes:
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
ECMO and advanced intensive care Euro-Elso 2013
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
Prevalence of statin and beta-blocker use by clinical presentation
VALUE Trial design: Hypertensive patients at high cardiovascular risk were randomized to valsartan (n = 7,649) vs. amlodipine (n = 7,596). Results (p =
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Atlantic Cardiovascular Patient Outcomes Research Team
Presentation transcript:

THE IMPACT OF ATRIAL FIBRILLATION IN CARDIAC SURGERY Wim J De Vries. DEPARTMENT CARDIOTHORACIC SURGERY UNIVERSITY OF THE FREE STATE UNIVERSITAS HOSPITAL

? Benign Rhythm ? Malignant Rhythm THE IMPACT OF ATRIAL FIBRILLATION IN CARDIAC SURGERY

New-onset. postoperative atrial fibrillation occurs in 30% of patients undergoing CABG, with the peak incidence on the second to third postoperative day It is associated with a 2- to 3-fold increase in postoperative risk for stroke. Patients at risk for postoperative atrial fibrillation have been identified and include those with COPD, proximal right CAD, prolonged cross-clamp time, atrial ischemia, advanced age, and withdrawal of beta-blockers. Identifying at-risk patients and directing treatment to these patients appears to be effective in reducing the incidence of nost-C ABG atrial fibrillation. And thus the morbid complication of postoperative strokes associated with this arrhythmia.Minimally invasive and.Qff pump beating- heart procedures may also reduce the incidence of postoperative atrial fibrillation Eagle and Guyton et al ACC/AHA Practice Guidelines INTRODUCTION

AIM AND METHODS AIM -Incidence of post operative Atrial fibrillation -Identify patients at risk for Atrial fibrillation -Morbidity and mortality of Atrial fibrillation

Methods 5 Year period, records of patients were prospectively entered in a Departemental database. AIM -Incidence of post operative Atrial fibrillation -Identify patients a risk for Atrial fibrillation -Morbidity and mortality of Atrial fibrillation AIM AND METHODS..

Total 1022 patients - OPCAB(301) - CABG(721 ) STUDY POPULATION

Total 1022 patients – OPCAB(29,4%) –CABG(70%) Males (72%) STUDY POPULATION

Total 1022 patients - OPCAB(301) - CABG(721) Males 798 – 72% Age (33-84) Mean 60,5 years STUDY POPULATION

Incidence of Atial Fibrillation N = Total ,7 %

RESULTS Male Sex Female Age > 65 Smoking Obesity Hypertension COPD Diabetes Rhythm Risk N %RROR ,2% 29,8% 54,9% 26,5% 56,9% 44,2% 11,9% 5,8% 52,9% 34,0% 13,9% 5,2% 29% 15% 2,3 2,07 1,2 1,25 1,5 2,6 1,9 5,5 3,3 1,6 1,20 2,1 2,8 2,9 P <0,0001 0,004 0,01 <0,001 0,005 0, A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus

RESULTS.. Renal imp Perif Vasc Pulm Hypert Previous MI Angina Unstable Stable Rhythm Risk N %RROR ,2% 3,5% 6,6% 2,4% 2,6% 1,4% 46,3% 42,7% 88% 69,4% 60,2% 49,7% 28,4% 19,7% 2,07 2,3 1,7 1,08 1,2 1,4 2,1 5,5 1,8 1,08 3,4 1,5 1,6 P 0,04 0,01 NS <0,0001 0, A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus

RESULTS.. Renal impairm Perif Vascular Pulm Hypert Previous MI Angina Unstable Stable Risk factor A- Fib Sinus RROR 2,07 2,3 1,7 1,08 1,2 1,4 2,1 5,5 1,8 1,08 3,4 1,5 1,6 P 0,04 0,01 NS <0,0001 0,01 3,5% 2,4% 1,4% 42,7% 69,4% 49,7% 19,7% 7,2% 6,6% 2,6% 46,3% 88% 1,2% 1,4% N=151N=871 (11) (10) (4) (70) (134) (91) (43) (31) (21) (13) (372) (605) (433) (172) % NN

RESULTS… CCS >= III ASA >= III NYHA >= III Emergent IABP Eject Frac Rhythm Risk N %RROR Med 54,3% 36,7% 71,5% 40,4% 43% 24% 15,2% 9,7% 20,5% 13,2% 59% 58% 1,4 1,7 1,6 1,5 2,04 3,7 2,3 1,7 1,6 P A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus <0,0001 0,02 NS

RESULTS…. Vessels Diseased LAD Right Sx Left Main # Dst Anas > 3 Off-Pump On Pump Perf Time Rhythm Risk N %RROR (M) 104(M) 84% 60% 59,6% 47,4% 20% 24,4% 13,9% 8,3% 68,2% 42,9% 7,3% 17,8% 1,3 1,2 0,83 1,8 1,5 0,4 2,5 1,5 0,52 2,06 2,8 0,36 P 0,0001 0,01 NS 0,006 <0,0001 NS A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus A-Fib Sinus

RESULTS…. Hospital Stay A-Fib + Hospital Stay Sinus Hospital Stay N %RROR 8(Median) 6(Median) P <0,

RESULTS….. Hospital Stay A-Fib Hospital Stay Sinus Stroke A-Fib + Stroke Sinus Stroke N %RROR 8(Median) 6(Median) 6,6% 3,05% P <0,0001 <0, /151 21/871 2,12,2

RESULTS…… Hospital Stay A-Fib Hospital Stay Sinus Stroke A- Fib + Stroke Sinus Mortality A- fib + Mortality Sinus Mortality N %RROR 8(M) 6(M) 6,6% 2,5% 11% 2.4% P <0,0001 <0,03 <0, /151 22/871 17/151 21/871 2,1 4,6 2,2 5,1

RISK PATIENTS Males Age > 65 Years Peripheral Vasc Dis Angina NYHA > III ASA > III CCS > III Emergent IABP On-Pump Surgery OR 5,5 3,3 5,5 3,4 2,3 3,7 2,04 1,7 1,6 0,36 P <0,0001 0,01 <0,0001 0,02 <0,0001

RISK PATIENTS.. Hypertension Smoking COPD Diabetes Renal Impairment Obesity LAD Lesion Right Lesion Left Main Disease # Distal Anastomosis >= 3 OR 2,17 1,6 2,9 2,5 2,1 1,2 2,5 1,5 2,06 2,8 P <0,001 <0,004 0,0001 0,03 0,04 0, 01 0,0001 0,01 0,006 <0,0001

Conclusion : Atrial Fibrillation Incidence 14,7% Mortality 11% Median hospital stay 8 days Incidence of stroke 6,6 %

Conclusion: Atrial Fibrillation.. Atrial Fibrillation is probably a marker of underlying disease Post operatively (Tip of the Iceberg). (Ears of hippopotamus) Atrial fibrillation Age Diabetes Hypertension On Pump Atrial Ischemia Atrial fibrillation Age Diabetes Hypertension On Pump Atrial Ischemia

MANAGEMENT Identify the risk patients Atrial fibrillation Age Diabetes Hypertension On Pump Atrial Ischemia

Identify the risk patients Non withdrawal of B Blockers MANAGEMENT.

Identify the risk patients Non withdrawal of B Blockers Prophylactic use of Amidiarone and or B Blockers MANAGEMENT..

Identify the risk patients Non withdrawal of B Blockers Prophylactic uses of Amidiorone and B Blockers Post operative overdrive pacing of the atrium MANAGEMENT…

Identify the risk patients Non withdrawal of B Blockers Prophylactic uses of Amidiarone and B Blockers Post operative pacing of the atrium Aggressive Treatment of Atrium Fibrillation Post operative to prevent stroke MANAGEMENT….

THANK YOU!!! Ke Ya Kopa!!!